Market Tracker

05/05 6:10am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.46
Delayed Data
As of May 04
 -0.23 / -0.90%
Today’s Change
24.83
Today|||52-Week Range
43.63
-40.49%
Year-to-Date

Today’s Trading

Previous close25.69
Today’s open25.56
Day’s range25.02 - 25.85
Volume580,304
Average volume (3 months)808,174
Market cap$1.2B
Dividend yield--
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-30.17%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio100.4
Price/Sales3.79
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-1.04-2.87%
ACHNAchillion Pharmaceut...-0.23-2.79%
CXRXConcordia Healthcare...+0.85+3.22%
INVAInnoviva Inc-0.13-1.11%
Data as of 05/04/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts